For instance, a heterozygous KCNQ1/TRPM4 dual mutation has been found in a LQTS patient, in whom verapamil treatment successfully reduced defibrillator discharge frequency by shortening the QT interval [71]. This evidence concerns the gene KCNQ1 and familial long QT syndrome.